InsiderTrades

Form 4 for DGX Quest Diagnostics

Accepted 2026-02-20 00:00:00 ET · period of report 2026-02-18 · accession 0001694295-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-02-20 2026-02-18 DGX SAMAD SAM EVP, CFO F - Tax $208.37 -1,865 28.9K -6% -$388.6K
DM 2026-02-20 2026-01-28+ DGX SAMAD SAM EVP, CFO A - Grant $3.14 +4,034 27.9K +17% +$12.7K
D 2026-02-20 2026-02-18 DGX SAMAD SAM EVP, CFO A - Grant $0.00 +18.3K 18.3K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-18 F D 1,010 $206.99 27,841 D — — (F2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
2 Common Common Stock 2026-02-18 F D 855 $210.01 28,851 D — — (F2) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.
3 Common Common Stock 2026-02-18 A A 3,965 $0.00 29,706 D — — (F1) Represents an award of restricted stock units.
4 Common Common Stock 2026-01-28 A A 69 $183.51 27,910 D — — (F3) Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
5 Derivative Non-Qualifed Stock Option (right to buy) 2026-02-18 A A 18,303 $0.00 18,303 D $204.96 · — to 2036-02-18 18,303 Common Stock (F4) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.